List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 74 studies with search of: "Poliomyelitis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV
Conditions: Poliomyelitis;   Polio
Interventions: Biological: Poliomyelitis Vaccine inactivated;   Biological: Poliomyelitis Vaccine in Dragee Candy (Human Diploid Cell)
2 Completed REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: REVAXIS®;   Biological: DT-Polio®
3 Completed Study of "Post-Polio Syndrome"
Conditions: Poliomyelitis;   Postpoliomyelitis Syndrome
Intervention:
4 Recruiting Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly
Condition: Poliomyelitis
Interventions: Biological: Inactivated types 1, 2, and 3 poliovirus, D antigens;   Biological: Inactivated types 1, 2, and 3 poliovirus, D antigens
5 Active, not recruiting Immunogenicity and Safety of Adacel Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TdcP-IPV vaccine
6 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
7 Active, not recruiting Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis vaccine (IMOVAX);   Biological: Inactivated Poliomyelitis vaccine (IMOVAX)
8 Recruiting Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-Year-Old Children.
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Boostrix Polio™ 711866;   Biological: Priorix Tetra TM 208136;   Biological: Tetravac TM
9 Completed Safety of Imovax Polio in Chinese Infants and Children
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis vaccine;   Biological: Inactivated Poliomyelitis vaccine
10 Completed Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
Condition: Post Polio Syndrome, PPS
Intervention: Drug: Xepol
11 Completed Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: Boostrix-Polio
12 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
13 Recruiting Study of Mental Fatigue in Polio Survivors
Condition: Post-Poliomyelitis Syndrome
Intervention:
14 Completed Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)
15 Enrolling by invitation Study of the DTacP-IPV-HepB-PRP-T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B
Intervention: Biological: DTaP-IPV-HB-PRP~T vaccine
16 Completed Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-HB-PRP~T;   Biological: DTaP-IPV//PRP~T combined vaccine & Recombinant hep B vaccine
17 Completed Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B
Interventions: Biological: DTaP-IPV-HB-PRP~T combined vaccine;   Biological: DTaP-IPV//PRP~T combined vaccine
18 Active, not recruiting Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Infections;   Pertussis
Intervention: Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac
19 Active, not recruiting Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type B
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
20 Active, not recruiting Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Conditions: Meningococcal Meningitis;   Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis
Interventions: Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services